Effect of Resveratrol Supplementation on Exercise Performance and Recovery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-40
SponsorUniversity of Central Florida
About this trial
To examine the effects of once daily supplementation with 500mg VeriSperse® resveratrol (VRES) for 17 days on muscle function, delayed onset muscle soreness, systemic concentrations of muscular damage markers and markers of oxidative stress in resistance trained young adult males following a damaging isoinertial squat protocol (ISP).
Eligibility criteria
Qualifiers
• Male between the ages of 18-40 years old
Healthy, and ready for physical activity as determined by the PAR-Q+, and MHQ.
Participants will be required to be recreationally active (defined according to ACSM standards of at least 150 minutes exercise per week).
Participants will be required to have been actively resistance training for a minimum of 6 months as defined by 3 resistance training sessions per week with at least one lower body session.
Disqualifiers
• Individual does not provide consent to participate in this study.
Inability to perform physical exercise (determined by MHQ, and PAR Q+). That is Answering "Yes" to any question on the PAR-Q +, or having a pre-existing condition such as musculoskeletal injury, back pain, chronic pain etc. that the investigative team perceives will prevent a participant from safely completing the protocol.
Not currently participating in at least 150 minutes of physical activity per week.
Not currently resistance trained (as defined within the inclusion criteria)
Trial design
Treatments tested in this trial
- Resveratrol (VRES) 500 mg oral once daily.
- Placebo 500 mg oral once daily.
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Central Florida
Lead sponsor
Gencor Pacific Group
Collaborator
Source ClinicalTrials.gov